HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

HLB Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Oct 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Market Capitalization	433,928	225,238	338,419	75,194	58,507	80,206
Market Cap Growth	127.72%	-33.44%	350.06%	28.52%	-27.05%	-
Enterprise Value	434,734	215,584	336,454	77,595	-	-
Last Close Price	12570.00	14781.18	22208.63	5003.85	3893.42	5916.16

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Oct 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
PE Ratio	151.20	49.27	167.55	159.09	-	-
PS Ratio	1.64	1.10	2.47	2.08	2.85	5.16
PB Ratio	3.15	1.80	2.91	4.20	3.44	4.77
P/TBV Ratio	3.28	1.86	3.02	4.31	3.50	4.83
P/FCF Ratio	-	-	83.73	-	-	-
P/OCF Ratio	95.26	395.87	49.47	55.56	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Oct 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
EV/Sales Ratio	1.64	1.05	2.45	2.15	-	-
EV/EBITDA Ratio	72.36	41.65	51.26	25.19	-	-
EV/EBIT Ratio	-	202.65	228.26	53.85	-	-
EV/FCF Ratio	-	-	83.24	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Oct 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Debt / Equity Ratio	0.15	0.17	0.14	0.74	0.45	0.89
Debt / EBITDA Ratio	3.12	4.00	2.45	4.28	-	-
Debt / FCF Ratio	-	-	3.97	-	-	-
Net Debt / Equity Ratio	0.01	-0.01	-0.05	-0.11	-0.08	0.21
Net Debt / EBITDA Ratio	0.13	-0.28	-0.90	-0.64	0.30	-1.27
Net Debt / FCF Ratio	-0.19	0.22	-1.47	44.86	0.49	-1.18
Asset Turnover	1.48	1.25	-	0.88	0.54	-
Inventory Turnover	4.65	3.79	-	3.27	3.13	-
Quick Ratio	1.07	1.17	1.02	1.01	0.94	1.01
Current Ratio	1.88	1.94	1.64	1.26	1.31	1.31
Return on Equity (ROE)	2.17%	3.79%	-	2.71%	-41.77%	-
Return on Assets (ROA)	0.69%	0.40%	-	2.19%	-9.55%	-
Return on Invested Capital (ROIC)	1.22%	0.83%	2.33%	9.14%	-32.41%	-18.92%
Return on Capital Employed (ROCE)	1.40%	0.80%	1.20%	6.30%	-28.80%	-17.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Oct 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Earnings Yield	0.67%	2.03%	0.60%	0.63%	-12.07%	-6.79%
FCF Yield	-1.04%	-2.95%	1.19%	-0.06%	-4.91%	-3.77%
Buyback Yield / Dilution	-1.71%	-1.96%	-131.51%	-2.30%	-13.08%	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 5, 2026

Data Sources Report a data error